Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-26-000009

Business Development Director sold 15,363 shares at $0.74 ($11,369)

  • Business Development Director gave up 253 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Christianson Mark · Business Development Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-30 Sale : show line 1 in the form −15,363 $0.74 $11,369 198,920 D
2026-03-31 Shares withheld for taxes : show line 2 in the form −253 $0.78 $197 198,667 D
Open-market sales · 15,363 sh · avg $0.74 · $11,369
Loading xslF345X06/primary_doc.xml…